Eczema monitoring online via questionnaires

Not Applicable

Completed

• Conditions: Eczema; Skin and Connective Tissue Diseases; Dermatitis and eczema

• Registration Number: ISRCTN45167024
• Lead Sponsor: niversity of Nottingham

Brief Summary

2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/36303217/ Effect on recruitment of social media strategy (added 31/10/2022) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37194567/ results (added 17/05/2023)

Detailed Description

Not available

Study Timeline

• Study Start: 2021-06-29
• Study Completion: 2022-04-03
• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 296

Inclusion Criteria

1. Self-report or parent/carer report of eczema diagnosis by a healthcare professional
2. Person aged 1 year or older
3. Able and willing to provide informed consent
4. If under 16 years old, a parent/carer needs to provide informed consent on behalf of the child
5. Able to read and understand written English
6. Have access to the internet and to an internet-enabled device
7. POEM score of 3 or above at eligibility screening

Exclusion Criteria

1. Unable/unwilling to provide informed consent
2. Currently taking part in another eczema clinical trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Eczema severity measured by the self-reported or proxy (parent/carer reported) POEM questionnaire score at baseline and 8 weeks

Secondary Outcome Measures

Name	Time	Method
1. Adherence to eczema treatment use, assessed in two ways:<br>1.1. Eczema treatment use assessed by the emollient and topical corticosteroid use questionnaire over the last week from baseline to 8 weeks<br>1.2. Eczema treatment use assessed by the overall eczema treatment use questionnaire 2 months prior to joining the study and at the end of the study at 8 weeks<br>2. Missing data: the proportion of fully completed questionnaires at 8 weeks